CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma

CD73 is involved in tumor immune escape and promotes the growth and progression of cancer cells. The functional role of CD73 expression in papillary thyroid carcinoma (PTC) has not yet been established. In 511 patients with PTC, immunohistochemistry for CD73 on tissue microarrays showed that the hig...

Full description

Bibliographic Details
Main Authors: Young Mun Jeong, Haejin Cho, Tae-Min Kim, Yourha Kim, Sora Jeon, Andrey Bychkov, Chan Kwon Jung
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/10/3042
_version_ 1797550550312550400
author Young Mun Jeong
Haejin Cho
Tae-Min Kim
Yourha Kim
Sora Jeon
Andrey Bychkov
Chan Kwon Jung
author_facet Young Mun Jeong
Haejin Cho
Tae-Min Kim
Yourha Kim
Sora Jeon
Andrey Bychkov
Chan Kwon Jung
author_sort Young Mun Jeong
collection DOAJ
description CD73 is involved in tumor immune escape and promotes the growth and progression of cancer cells. The functional role of CD73 expression in papillary thyroid carcinoma (PTC) has not yet been established. In 511 patients with PTC, immunohistochemistry for CD73 on tissue microarrays showed that the high expression of CD73 was associated with an aggressive histologic variant (<i>p</i> = 0.002), extrathyroidal extension (<i>p</i> < 0.001), lymph node metastasis (<i>p</i> < 0.001), and <i>BRAF</i><sup>V600E</sup> mutation (<i>p</i> = 0.015). Survival analysis results showed that patients with high CD73 expression had worse recurrence-free survival (<i>p</i> = 0.023). CD73 inhibitors induced G1 cell cycle arrest and apoptosis, inhibited the migration and invasion of PTC cells, and suppressed tumor growth in PTC xenograft nude mice. High expression of CD73 (<i>NT5E</i>) mRNA was associated with unfavorable clinicopathologic characteristics, the abundance of Tregs and dendritic cells, depletion of natural killer (NK) cells, and high expression of immune checkpoint genes and epithelial-to-mesenchymal transition-related genes in The Cancer Genome Atlas (TCGA) dataset. Taken together, CD73 expression promotes tumor progression and predicts low recurrence-free survival. Targeting the CD73–adenosine axis in the tumor microenvironment offers an attractive pathway for therapeutic strategies aimed at advanced PTC.
first_indexed 2024-03-10T15:30:57Z
format Article
id doaj.art-d47dc493963e4fe099ee2030ca0a0e23
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T15:30:57Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-d47dc493963e4fe099ee2030ca0a0e232023-11-20T17:41:32ZengMDPI AGCancers2072-66942020-10-011210304210.3390/cancers12103042CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid CarcinomaYoung Mun Jeong0Haejin Cho1Tae-Min Kim2Yourha Kim3Sora Jeon4Andrey Bychkov5Chan Kwon Jung6Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, KoreaCancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, KoreaCancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, KoreaDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, KoreaDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, KoreaDepartment of Pathology, Kameda Medical Center, Kamogawa, Chiba 296-8602, JapanDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, KoreaCD73 is involved in tumor immune escape and promotes the growth and progression of cancer cells. The functional role of CD73 expression in papillary thyroid carcinoma (PTC) has not yet been established. In 511 patients with PTC, immunohistochemistry for CD73 on tissue microarrays showed that the high expression of CD73 was associated with an aggressive histologic variant (<i>p</i> = 0.002), extrathyroidal extension (<i>p</i> < 0.001), lymph node metastasis (<i>p</i> < 0.001), and <i>BRAF</i><sup>V600E</sup> mutation (<i>p</i> = 0.015). Survival analysis results showed that patients with high CD73 expression had worse recurrence-free survival (<i>p</i> = 0.023). CD73 inhibitors induced G1 cell cycle arrest and apoptosis, inhibited the migration and invasion of PTC cells, and suppressed tumor growth in PTC xenograft nude mice. High expression of CD73 (<i>NT5E</i>) mRNA was associated with unfavorable clinicopathologic characteristics, the abundance of Tregs and dendritic cells, depletion of natural killer (NK) cells, and high expression of immune checkpoint genes and epithelial-to-mesenchymal transition-related genes in The Cancer Genome Atlas (TCGA) dataset. Taken together, CD73 expression promotes tumor progression and predicts low recurrence-free survival. Targeting the CD73–adenosine axis in the tumor microenvironment offers an attractive pathway for therapeutic strategies aimed at advanced PTC.https://www.mdpi.com/2072-6694/12/10/3042thyroid cancerCD735′-Nucleotidasetumor microenvironmentepithelial–mesenchymal transition
spellingShingle Young Mun Jeong
Haejin Cho
Tae-Min Kim
Yourha Kim
Sora Jeon
Andrey Bychkov
Chan Kwon Jung
CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
Cancers
thyroid cancer
CD73
5′-Nucleotidase
tumor microenvironment
epithelial–mesenchymal transition
title CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
title_full CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
title_fullStr CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
title_full_unstemmed CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
title_short CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
title_sort cd73 overexpression promotes progression and recurrence of papillary thyroid carcinoma
topic thyroid cancer
CD73
5′-Nucleotidase
tumor microenvironment
epithelial–mesenchymal transition
url https://www.mdpi.com/2072-6694/12/10/3042
work_keys_str_mv AT youngmunjeong cd73overexpressionpromotesprogressionandrecurrenceofpapillarythyroidcarcinoma
AT haejincho cd73overexpressionpromotesprogressionandrecurrenceofpapillarythyroidcarcinoma
AT taeminkim cd73overexpressionpromotesprogressionandrecurrenceofpapillarythyroidcarcinoma
AT yourhakim cd73overexpressionpromotesprogressionandrecurrenceofpapillarythyroidcarcinoma
AT sorajeon cd73overexpressionpromotesprogressionandrecurrenceofpapillarythyroidcarcinoma
AT andreybychkov cd73overexpressionpromotesprogressionandrecurrenceofpapillarythyroidcarcinoma
AT chankwonjung cd73overexpressionpromotesprogressionandrecurrenceofpapillarythyroidcarcinoma